Morten O. Andersen

Roskilde, 4000, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 135 publications

Mathematical modeling of JAK2V617F clonal expansion in a general population cohort.

Mathematical modeling of JAK2V617F clonal expansion in a general population cohort.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 17, 2026

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Journal: Mathematical biosciences

Published: January 22, 2026

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Journal: Mathematical biosciences

Published: January 22, 2026

Early adoption patterns of the recombinant zoster vaccine: real-world versus clinical trial populations.

Early adoption patterns of the recombinant zoster vaccine: real-world versus clinical trial populations.

Journal: Infectious diseases (London, England)

Published: December 03, 2025

The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortality.

The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortality.

Journal: Journal of internal medicine

Published: November 06, 2025

Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium-glucose cotransporter 2 inhibitor users.

Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium-glucose cotransporter 2 inhibitor users.

Journal: British journal of clinical pharmacology

Published: October 21, 2025

The future of mathematical oncology in the age of AI.

The future of mathematical oncology in the age of AI.

Journal: NPJ systems biology and applications

Published: September 30, 2025

Modeling the evolutionary dynamics of clonal hematopoiesis.

Modeling the evolutionary dynamics of clonal hematopoiesis.

Journal: Nature genetics

Published: August 15, 2025

Persistent musculoskeletal pain and its association with future mental distress in adolescents: The Fit Futures study.

Persistent musculoskeletal pain and its association with future mental distress in adolescents: The Fit Futures study.

Journal: BMC public health

Published: July 03, 2025

Sexual Dysfunction in Male Patients After Initiating Treatment with Antidepressants.

Sexual Dysfunction in Male Patients After Initiating Treatment with Antidepressants.

Journal: Drug safety

Published: April 23, 2025

Nationwide Real-World Outcomes of Trial Eligible and Trial Ineligible Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab.

Nationwide Real-World Outcomes of Trial Eligible and Trial Ineligible Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab.

Journal: Clinical genitourinary cancer

Published: April 09, 2025

Understanding the Work of the Pharmacovigilance Risk Assessment Committee (PRAC): A Quantitative Review of the Post-Authorisation Safety Evaluation of Antidiabetic Drugs from 2012 to 2022.

Understanding the Work of the Pharmacovigilance Risk Assessment Committee (PRAC): A Quantitative Review of the Post-Authorisation Safety Evaluation of Antidiabetic Drugs from 2012 to 2022.

Journal: Drug safety

Published: February 17, 2025

Showing 1-12 of 135

Last Updated: 09/26/2026